Back to top
more

Encompass Health (EHC)

(Delayed Data from NYSE)

$98.03 USD

98.03
1,643,923

+0.14 (0.14%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $98.01 -0.02 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (77 out of 247)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Can Technology and Cost Discipline Lift DaVita's Q3 Earnings?

by Zacks Equity Research

DVA's third-quarter 2025 performance is likely to benefit from technology upgrades and cost control while battling high missed treatments and low volume growth.

Sumit Singh headshot

4 Stocks With Strong Interest Coverage Ratios to Buy Now

by Sumit Singh

Stride, Ralph Lauren, Encompass Health and Boot Barn stand out with robust interest coverage ratios and strong growth outlooks.

Zacks Equity Research

HCA Q3 Earnings Beat Estimates on Rising Inpatient Surgery Cases

by Zacks Equity Research

HCA Healthcare's Q3 earnings rise 42% y/y on stronger patient volumes and rising inpatient surgeries, prompting management to lift its 2025 outlook.

Zacks Equity Research

Community Health Q3 Earnings Beat on Rising Same-Store Admissions

by Zacks Equity Research

CYH's Q3 earnings surge on higher same-store admissions, cost cuts and a stronger payor mix, swinging to a $171M profit from a loss last year.

Zacks Equity Research

Here's How Charles River Stock Is Placed Ahead of Q3 Earnings

by Zacks Equity Research

CRL heads into Q3 earnings with steady RMS growth but faces DSA headwinds from tight biotech budgets.

Zacks Equity Research

Option Care (OPCH) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why Encompass Health (EHC) is a Strong Growth Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Here's How Henry Schein Is Placed Ahead of Q3 Earnings

by Zacks Equity Research

HSIC heads into Q3 with solid gains expected across Dental, Specialty and Tech segments, though earnings estimates have slipped slightly.

Zacks Equity Research

Encompass Health (EHC) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Universal Health to Report Q3 Earnings: Key Estimates to Note

by Zacks Equity Research

UHS is likely to have posted Q3 revenue and earnings growth, driven by strong hospital and behavioral health segments despite cost pressures.